Indivior PLC (LON:INDV – Get Free Report) shares crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 924.25 ($11.50) and traded as high as GBX 982 ($12.22). Indivior shares last traded at GBX 960 ($11.94), with a volume of 6,576,867 shares changing hands.
Analyst Ratings Changes
Separately, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 1,800 ($22.40) price objective on shares of Indivior in a report on Tuesday, December 17th.
Get Our Latest Stock Report on INDV
Indivior Stock Performance
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
See Also
- Five stocks we like better than Indivior
- What Are Trending Stocks? Trending Stocks Explained
- Sizing Up a New Opportunity for NVIDIA Investors
- How to Invest in Biotech Stocks
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.